Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Drug Resistance

Free Subscription 17.08.2026 1 Infect Control Hosp Epidemiol 3 Int J Antimicrob Agents 4 J Antimicrob Chemother 5 J Clin Microbiol 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Infect Control Hosp Epidemiol

1. LEVANDOWSKI R, Hwang TY, Lee KS
   Growing carbapenem resistance in South Korea with long-term care facilities as reservoirs.
   Infect Control Hosp Epidemiol. 2026 Aug 10:1-3. doi: 10.1017/ice.2026.10520.
   PubMed         Abstract available
   
   

   
   Int J Antimicrob Agents

2. DOMINGUES CPF, Rebelo JS, Dionisio F, Nogueira T, et al
   Drivers of antimicrobial resistance gene clustering in plasmids: distribution, host clinical relevance, and plasmid mobility.
   Int J Antimicrob Agents. 2026 Aug 13:107964.
   PubMed         Abstract available
   
   
3. HE J, Li N, Li X, Chen Y, et al
   Intrapulmonary pharmacokinetics and safety of eravacycline in critically ill patients with HAP/VAP caused by carbapenem-resistant Acinetobacter baumannii and Enterobacterales: a prospective study.
   Int J Antimicrob Agents. 2026 Aug 11:107960.
   PubMed         Abstract available
   
   
4. WANG R, Yang S, Jin L, Li B, et al
   Emergence of Cefiderocol Resistance in Carbapenem-Resistant Escherichia coli ST167 Prior to Clinical Use: A Multifactored Resistance Landscape.
   Int J Antimicrob Agents. 2026 Aug 10:107958.
   PubMed         Abstract available
   
   

   
   J Antimicrob Chemother

5. BELLECAVE P, Peyrouny-Mazeau A, Leleux O, Hessamfar M, et al
   Factors associated with virological failure in people with HIV treated with bictegravir/emtricitabine/tenofovir alafenamide. Impact of pre-existing mutations and risk of resistance emergence. ANRS-CO3-AquiVIH-NA cohort.
   J Antimicrob Chemother. 2026;81:dkag278.
   PubMed         Abstract available
   
   
6. FREIRE S, Alvarez SM, Findlay J, Vogel M, et al
   Characterization of the intrinsic AmpC beta-lactamase of Escherichia marmotae and its impact on decreased susceptibility to cefiderocol and resistance to broad-spectrum cephalosporins.
   J Antimicrob Chemother. 2026;81:dkag271.
   PubMed         Abstract available
   
   
7. ROUABAH L, Ronsin S, Vasseur A, Rezzoug I, et al
   Epidemiology of KPC-producing Enterobacterales isolated from 2019 to 2023 in France.
   J Antimicrob Chemother. 2026;81:dkag273.
   PubMed         Abstract available
   
   
8. BOSNAK C, Metan G, Zarakolu P, Karakulak EA, et al
   Determinants of levofloxacin prophylaxis failure in high-risk haematology patients: a prospective study integrating resistant colonization and pharmacokinetic/pharmacodynamic target attainment.
   J Antimicrob Chemother. 2026;81:dkag284.
   PubMed         Abstract available
   
   

   
   J Clin Microbiol

9. DINGEMANS J, Vandersanden S, Hilkens P, Godelaine J, et al
   Applicability of Nanopore-only whole-genome sequencing for Pseudomonas aeruginosa outbreak investigation in the ICU setting: a multicentric study.
   J Clin Microbiol. 2026;64:e0057226.
   PubMed         Abstract available
   
   
10. DEWAELE K, Jouego C, Asim A, Laenen L, et al
    Open-access genomic drug resistance prediction tools for Mycobacterium tuberculosis: a systematic review and meta-analysis.
    J Clin Microbiol. 2026 Jul 27:e0032126. doi: 10.1128/jcm.00321.
    PubMed         Abstract available
    
    
11. LI H-L, Fan Y-L, Zhong T, Lin B-Y, et al
    Synonymous codon-optimized multiplex qPCR for simultaneous detection of Helicobacter pylori and precise drug resistance profiling in infected individuals.
    J Clin Microbiol. 2026 Jul 27:e0186125. doi: 10.1128/jcm.01861.
    PubMed         Abstract available
    
    
12. SMITH DJ, van Beurden T, Li Y, Almeida-Paes R, et al
    Establishment of epidemiological cutoff values against Fonsecaea monophora, an agent of chromoblastomycosis and cerebral phaeohyphomycosis.
    J Clin Microbiol. 2026;64:e0184625.
    PubMed         Abstract available
    
    
13. SVENSSON E, Folkvardsen DB, Norman A, Rasmussen EM, et al
    Increased sensitivity of the updated FluoroType MTBDR V2 with addition of IS6110 analysis.
    J Clin Microbiol. 2026;64:e0026826.
    PubMed         Abstract available
    
    

    
    PLoS One

14. GETACHEW Y, Tamiru T, Fisseha M, Sebri S, et al
    Multidrug resistance and carbapenemase producing Enterobacteriaceae isolated from clinical samples, Addis Ababa, Ethiopia: A cross-sectional study.
    PLoS One. 2026;21:e0356234.
    PubMed         Abstract available
    
    
15. NEMIDKANAM V, Ahmed R, Chaichanawongsaroj N
    Identification of high-risk extended-spectrum beta-lactamase-producing Escherichia coli clones harboring tet(X4) along the pork supply chain in central Thailand.
    PLoS One. 2026;21:e0355459.
    PubMed         Abstract available
    
    
16. YUSUF YM, Desta AF, Ayana D, Aychegrew HN, et al
    Genomic epidemiology of multidrug-resistant and ESBL-producing Proteus mirabilis in a military referral hospital in Ethiopia.
    PLoS One. 2026;21:e0355508.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum